Ciara Louise Freeman

Comparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma

Doris K. Hansen, Lauren C. Peres, Danai Dima et al. · Journal of Clinical Oncology · 2025 · 35 citations · Full text

Medicine, Immunology, Oncology +16

Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial

Ciara Louise Freeman, Binod Dhakal, Gurbakhash Kaur et al. · Blood · 2024 · 18 citations · Full text

Medicine, Hematology, Oncology +9

Pattern of Cytokine Release in Patients with Chronic Lymphocytic Leukemia Treated with Obinutuzumab and Possible Relationship with Development of Infusion Related Reactions (IRR)

Ciara Louise Freeman, Franck Morschhauser, Laurie H. Sehn et al. · Blood · 2014 · 11 citations

Life Sciences, Immunology, Oncology +17

Risk Factors Associated with the Development of Infusion-Related Reactions in Patients with Chronic Lymphocytic Leukaemia Treated with Anti-CD20 Monoclonal Antibodies: Analysis of the CLL11 Study Dataset

Ciara Louise Freeman, Mark Dixon, Richard Houghton et al. · Blood · 2014 · 10 citations

Pharmacy, Hematology, Immunology +17